The diagnosis and treatment methods for advanced lung cancer are constantly developing and improving, and more and more patients are able to "restart their lives". The prolonged survival period has also given rise to a new demand for long-term management of lung cancer patients, which requires the joint participation of more forces. In the field of cancer, patients who live for more than 5 years can be considered as successfully treated, and the disease gradually becomes chronic. We hope that by 10 years, more than half of the patients will not relapse. This is also the goal of scientists and clinical doctors working together. "Wu Yilong, Chief Expert of Guangdong Provincial People's Hospital and Honorary Director of Guangdong Provincial Lung Cancer Research Institute, recently said at the" Adding Time to Life: Breakthroughs and Prospects for Long term Survival of Advanced Lung Cancer "series of salon activities. With the rapid development of medical technology, the survival rate of lung cancer has greatly improved. According to the National Cancer Center/Cancer Hospital of the Chinese Academy of Medical Sciences, the overall five-year survival rate of lung cancer has reached 28.7%, with the largest increase among all types of tumors. However, it should be pointed out that although the survival rate of lung cancer has significantly improved, there is still a considerable distance to go before the main goal of "achieving a 5-year overall cancer survival rate of 46.6% by 2030" in the "Healthy China Action - Cancer Prevention and Control Action Implementation Plan (2023-2030)". Innovative anti-tumor drugs have greatly provided more weapons for the clinical treatment of lung cancer. With the extension of patient survival, the participation of patients and their families in out of hospital management also has a significant impact on the treatment effectiveness of the disease. In Wu Yilong's view, the ultimate goal of treatment is to enable patients to return to society and normal life as soon as possible. Therefore, it often requires more active communication between doctors and patients to make treatment decisions together. Tang Kejing, director of the Pharmacy Department of the First Affiliated Hospital of Sun Yat sen University, also believes that "patient-centered" requires more communication with patients and their families to discuss treatment plans and expectations for treatment outcomes, in order to provide more accurate and personalized treatment. The cooperation of patients and their compliance with treatment have a significant impact on clinical outcomes. On the one hand, we need to encourage patients to actively cooperate with treatment while understanding their own condition. On the other hand, we also need to monitor adverse drug reactions and manage the entire process of long-term treatment, and provide more support to patients in terms of drug accessibility and affordability, helping them live longer and better. To further improve the overall survival rate of lung cancer, we need to move the prevention and treatment checkpoint forward, promote healthy lifestyles, and help more people prevent the disease; At the same time, it is necessary to popularize the concept of early screening and diagnosis. Nowadays, clinical doctors face the dilemma of how to choose from numerous treatment options, but this is also a happy dilemma, "said Cao Yang, director of the Cancer Center of the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine. Achieve the target of 6% Yan Honghong, a biostatistician at Guangdong Provincial Lung Cancer Research Institute, said. (New Society)